Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Davis, Ben ^a   Ladner, Joel ^b   Sams, Kelley ^c   Tekinturhan, Ebru ^a   De Korte, Donald ^d   Saba, Joseph ^a  

^a Axios International   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

ACT; AMFm; Global fund; Malaria treatment; Private

Indexed keywords

ARTEMISININ;

ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG MARKETING; HEALTH CARE COST; NIGERIA; PHARMACY; QUESTIONNAIRE; RURAL AREA; UGANDA; URBAN AREA;

AFRICA; ARTEMISININS; DRUG THERAPY, COMBINATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERVIEWS AS TOPIC; MALARIA; PHARMACIES; PRIVATE SECTOR; PROGRAM EVALUATION; QUESTIONNAIRES;

EID: 84876724562     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-135     Document Type: Article

References (18)

1. WHO, World Malaria Report 2011 Geneva: World Health Organization 2011
2. WHO, Guidelines for the treatment of malaria Geneva: World Health Organization 2006
3. WHO, Guidelines for the treatment of malaria Geneva: World Health Organization 2 2010
4. Pricing, distribution, and use of antimalarial drugs. Foster SD, Bull World Health Organ 1991 69 349 363 1893512
5. Improving malaria home treatment by training drug retailers in rural Kenya. Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, Ross A, Marsh K, Trop Med Int Health 2004 9 451 460 10.1111/j.1365-3156.2004.01223.x 15078263
6. Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities. Whitty CJ, Chandler C, Ansah E, Leslie T, Staedke SG, Malar J 2008 7 Suppl 1 7 10.1186/1475-2875-7-S1-S7 19091041
7. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P, Trop Med Int Health 2004 9 655 663 10.1111/j.1365-3156. 2004.01245.x 15189455
8. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, Munroe E, Chapman S, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Shewchuk T, Chavasse D, O'Connell KA, Malar J 2011 10 327 10.1186/1475-2875-10- 327 22039892
9. The Glboal Fund to Fight AIDS, Tuberculosis, and Malaria, Quality assurance policy for pharmaceutical products 2010 Available at http://www.theglobalfund.org/documents/psm/PSM-QAPharm-Policy-en/ Accessed November 14, 2012
10. IFC International, Independent evaluation of the Affordable Medicines Facility-malaria (AMFm) Phase 1 The Global Fund to Fight AIDS, Tuberculosis, and Malaria Multi-Country Baseline Report. 2012
11. WHO, Briefing on Malaria Treatment Guidelines and artemisinin monotherapies Geneva: World Health Organization 2006
12. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP, Malar J 2009 8 253 10.1186/1475-2875-8-253 19906307
13. The Global Fund to Fight AIDS, Tuberculosis, and Malaria, Affordable Medicine Facility-malaria: Reports and co-payments Available at http://www.theglobalfund.org/en/amfm/firstlinebuyers/reports/ Accessed November 14, 2012
14. Heatlh Action International, Retail prices of ACTs co-paid by the AMFm and other antimalarial medicines: Ghana, Kenya, Madagascar, Nigeria, Tanzania and Uganda Geneva, Switzerland: The Global Fund to Fight AIDS, Tuberculosis, and Malaria
15. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia. Yeung S, Patouillard E, Allen H, Socheat D, Malar J 2011 10 243 10.1186/1475-2875-10-243 21851625
16. The Global Fund to Fight AIDS, Tuberculosis and Malaria, Board approves integration of AMFm into core Global Fund grant process News Release. November 15, 2012. Available at: http://www.theglobalfund.org/en/mediacenter/ newsreleases/2012-11-15-Board-Approves-Integration-of-AMFm-into-Core-Global- Fund-Grant-Processes/
17. Malaria plan under scrutiny. Maxmen A, Nature 2012 490 13 14 10.1038/490013a 23038440
18. Effect of the affordable medicines facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Tougher S, Ye Y, Amuasi JH, Kourgueni IA, Thomson R, Goodman C, Mann AG, Ren R, Willey BA, Adegoke CA, Amin A, Ansong D, Bruxvoort K, Diallo DA, Diap G, Festo C, Johanes B, Juma E, Kalolella A, Malam O, Mberu B, Ndiaye S, Nguah SB, Seydou M, Taylor M, Rueda ST, Wamukoya M, Arnold F, Hanson K, Lancet 2012 380 1916 1926 10.1016/S0140-6736(12)61732-2 23122217